Pharmaceutical Technology
April 06, 2020
Peer-Review Research
44
4
This case study highlights analytical instrumentation and techniques that were used to identify an unknown impurity detected during routine release testing of a topical gel drug product.
April 03, 2020
Manufacturing
44
4
Advanced analytics and modeling can be used to predict downstream failures, allowing for corrective action before batches are lost.
April 02, 2020
Regulatory Watch
44
4
FDA is encouraging alternative insulins and challenging anticompetitive practices.
April 02, 2020
Ask the Expert
44
4
Addressing data integrity, quality culture, aging facilities, investigations/corrective actions and preventive actions, and risk management is key when conducting audits, says Susan J. Schniepp, executive vice-president of post-approval pharma and distinguished fellow, Regulatory Compliance Associates.
April 02, 2020
Development
44
4
Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe.
April 02, 2020
Product Spotlight
44
4
The Nexera UC Prep, a preparative supercritical fluid chromatography (SFC) system from Shimadzu, works to provide maximum use of lab resources through flexible system configurations in a compact design that requires low installation space.
April 02, 2020
Product Spotlight
44
4
The QF2500 Quaternary Diaphragm Pump from Quattroflow, part of PSG, a Dover company, extends the company’s range of pumps.
April 02, 2020
Product Spotlight
44
4
The 20,000-gallon storage vessel from Ross Engineering measures at 10.5-ft outer diameter x 30-ft. long and is designed for product storage under atmospheric pressure at 200 ºF; it is UL-142 rated.
April 02, 2020
Product Spotlight
44
4
Porvair Sciences introduced Microlute SLE 96-well plates and cartridges for the easy extraction of acidic, basic, and neutral analytes from samples, with greater reproducibility.
April 02, 2020
Analytics
44
4
Because conventional cleaning methods can risk product loss, biopharmaceutical manufacturers are often reluctant to use PDE/ADE limits to validate cleaning processes.
April 02, 2020
From the Editor
44
4
As the coronavirus pandemic unfolds, Pharma must practice science over hype.
April 02, 2020
Quality/Regulations
44
4
With ingredients sold to multiple markets, excipient manufacturers must understand the different regulatory requirements for pharma vs. food.
April 02, 2020
Operations
44
4
More sustainable and functional packaging protects temperature-sensitive drugs.
April 02, 2020
Regulatory Watch
44
4
Regulatory emergency planning has been put to the test with the COVID-19 pandemic.
April 02, 2020
From the Editor
44
4
As COVID-19 rapidly spreads, the bio/pharma industry is committing significant efforts to fast track development of therapies.
April 02, 2020
Development
44
4
Considering the potential interaction of a drug with the delivery device early on in in development is integral to achieving the best combination.
April 02, 2020
Development
44
4
The new molecules entering the development pipeline are bringing forth exciting challenges in drug delivery.
April 02, 2020
Manufacturing
44
4
Risk levels should be considered when designing containment for pharmaceutical tableting equipment to enhance operator safety.
April 02, 2020
Operations
44
4
Pharmaceutical Technology spoke with Jens Andersson, purchasing director at Cambrex Karlskoga, about the best way to ensure the security of the bio/pharmaceutical materials supply chain.
April 02, 2020
Operations
44
4
Risk assessments, audits, and good communication between sponsor and supplier are key elements of supplier oversight.
April 02, 2020
Cover Story: Manufacturing Trends
44
4
Whether refitting existing spaces or building new, the need for quick build times, flexibility, and production efficiency is driving trends in bio/pharma facility construction.
April 02, 2020
Issue PDF
44
4
Click the title above to open the Pharmaceutical Technology April 2020 issue in an interactive PDF format.
April 02, 2020
Outsourcing
44
4
But are innovations sufficient to increase adoption? CMOs are demanding better continuous bioprocessing options.